Know Cancer

or
forgot password
  • cancer clinical trials in little rock, AR

  • S9810: Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by Surgery
    University of Arkansas for Medical Sciences

    Trial Locations
    University of Arkansas for Medical Sciences
    Veterans Affairs Medical Center - Little Rock (McClellan)
    Malignant Mesothelioma
    Fludarabine With or Without Cyclophosphamide in Treating Patients With Chronic Lymphocytic Leukemia
    University of Arkansas for Medical Sciences

    Trial Locations
    University of Arkansas for Medical Sciences
    Veterans Affairs Medical Center - Little Rock (McClellan)
    Leukemia
    S9911, Combination Chemotherapy Plus Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma
    Veterans Affairs Medical Center - Little Rock (McClellan)
    Little Rock, Arkansas 72205
    Lymphoma
    S9809, Ciprofloxacin Compared With Cephalexin in Treating Patients With Bladder Cancer
    University of Arkansas for Medical Sciences

    Trial Locations
    University of Arkansas for Medical Sciences
    Veterans Affairs Medical Center - Little Rock (McClellan)
    Bladder Cancer
    4'-Iodo-4'-Deoxydoxorubicin in Treating Patients With Primary Systemic Amyloidosis
    University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Multiple Myeloma and Plasma Cell Neoplasm
    Thalidomide in Treating Patients With Chronic Graft-Versus-Host Disease Following Bone Marrow Transplant
    Arkansas Children's Hospital
    Little Rock, Arkansas 72202-3591
    Graft Versus Host Disease, Unspecified Adult Solid Tumor, Protocol Specific, Unspecified Childhood Solid Tumor, Protocol Specific
    Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Breast Cancer
    S9902 Docetaxel Plus Carboplatin in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
    University of Arkansas for Medical Sciences

    Trial Locations
    University of Arkansas for Medical Sciences
    Veterans Affairs Medical Center - Little Rock (McClellan)
    Head and Neck Cancer
    Combination Chemotherapy Plus Dexrazoxane in Treating Patients With Newly Diagnosed Nonmetastatic Osteosarcoma
    University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Cardiac Toxicity, Sarcoma
    S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Prostate Cancer
    S9914: Combination Chemotherapy Plus Filgrastim in Untreated Extensive-Stage Small Cell Lung Cancer
    University of Arkansas for Medical Sciences

    Trial Locations
    University of Arkansas for Medical Sciences
    Veterans Affairs Medical Center - Little Rock (McClellan)
    Lung Cancer
    Combination Chemotherapy in Treating Children or Adolescents With Newly Diagnosed Stage III or Stage IV Lymphoblastic Lymphoma
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Lymphoma
    S9915 Triacetyluridine, Fluorouracil, and Leucovorin in Treating Patients With Unresectable, Locally Advanced, or Metastatic Cancer of the Esophagus or Stomach
    University of Arkansas for Medical Sciences

    Trial Locations
    University of Arkansas for Medical Sciences
    Veterans Affairs Medical Center - Little Rock (McClellan)
    Esophageal Cancer, Gastric Cancer
    Combination Chemotherapy With or Without Dexrazoxane in Treating Children With Hodgkin's Disease
    University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Cardiac Toxicity, Lymphoma
    Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Leukemia
    Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Leukemia
    S9926 Temozolomide in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumors
    University of Arkansas for Medical Sciences

    Trial Locations
    University of Arkansas for Medical Sciences
    Veterans Affairs Medical Center - Little Rock (McClellan)
    Gastrointestinal Stromal Tumor
    Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia
    University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Leukemia, Lymphoma
    S0010 506U78 in Treating Patients With Recurrent or Refractory Acute Lymphocytic Leukemia
    University of Arkansas for Medical Sciences

    Trial Locations
    University of Arkansas for Medical Sciences
    Veterans Affairs Medical Center - Little Rock (McClellan)
    Leukemia
    S0007 - Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
    University of Arkansas for Medical Sciences

    Trial Locations
    University of Arkansas for Medical Sciences
    Veterans Affairs Medical Center - Little Rock (McClellan)
    Head and Neck Cancer
    Paclitaxel With or Without Gemcitabine in Treating Women With Advanced Breast Cancer
    Little Rock Hematology-Oncology Associates
    Little Rock, Arkansas 72205
    Breast Cancer
    Ecteinascidin 743 in Treating Children With Refractory Solid Tumors
    University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Unspecified Childhood Solid Tumor, Protocol Specific
    Biafine Cream to Reduce Side Effects of Radiation Therapy in Patients Receiving Treatment for Advanced Head and Neck Cancer
    University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Head and Neck Cancer, Skin Reactions Secondary to Radiation Therapy
    Combination Chemotherapy With or Without Tirapazamine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
    University of Arkansas for Medical Sciences

    Trial Locations
    University of Arkansas for Medical Sciences
    Veterans Affairs Medical Center - Little Rock (McClellan)
    Lung Cancer
    S0019 Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
    University of Arkansas for Medical Sciences

    Trial Locations
    University of Arkansas for Medical Sciences
    Veterans Affairs Medical Center - Little Rock (McClellan)
    Lymphoma
    Glutamine in Treating Mucositis Caused by Radiation Therapy in Patients With Newly Diagnosed Cancer of the Mouth or Throat
    Veterans Affairs Medical Center - Little Rock (McClellan)

    Trial Locations
    Veterans Affairs Medical Center - Little Rock (McClellan)
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Cancer-related Problem/Condition, Head and Neck Cancer, Pain
    Interleukin-2 in Treating Children Who Have Undergone Bone Marrow Transplantation for Acute Myeloid Leukemia
    Arkansas Children's Hospital
    Little Rock, Arkansas 72202-3591
    Leukemia
    Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer
    Veterans Affairs Medical Center - Little Rock (McClellan)

    Trial Locations
    Veterans Affairs Medical Center - Little Rock (McClellan)
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    S0101 Gemcitabine and Irinotecan in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus
    Veterans Affairs Medical Center - Little Rock (McClellan)
    Little Rock, Arkansas 72205
    Esophageal Cancer, Gastric Cancer
    S0031, ZD 1839 in Treating Patients With Advanced Cancer of the Urinary Tract
    University of Arkansas for Medical Sciences

    Trial Locations
    University of Arkansas for Medical Sciences
    Veterans Affairs Medical Center - Little Rock (McClellan)
    Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer